Purchasing guide for sotoraxibu, the price is absolutely beyond imagination compared with the original drug

Sotorasib is a new anti-cancer drug that is a KRAS G12C inhibitor. KRAS is a gene involved in cell signaling, and KRAS G12C is one of the mutant forms, which is common in certain cancers, especially non-small cell lung cancer (NSCLC). Sotoracib was developed to provide a targeted treatment for this specific genetic mutation.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.

Its mechanism of action mainly inhibits the growth and reproduction of cancer cells by inhibiting KRAS G12C mutant. The drug is unique in that it interferes with tumor cell signaling pathways, thereby slowing the progression of cancer. In some studies and clinical trials, sotorasiib has shown some efficacy in patients with KRAS G12C mutated NSCLC.

Treatment regimens with sotoraxib are usually developed by your doctor based on the patient's specific situation. The introduction of this drug provides a new treatment option for patients who have undergone other treatments but still harbor theKRAS G12Cmutation. However, like any drug, sotoraxib may cause some side effects, so its use requires medical supervision and guidance.

Overall, sotoracib represents an innovative development in the field of cancer treatment, providing a more precise treatment plan for specific genetic mutation types of cancer, and is expected to bring better survival and quality of life to patients.